Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 3Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Sleep Initiation and Maintenance Disorders 1Prostatic Neoplasms 1Liver Neoplasms 1Fatigue 1Colorectal Neoplasms 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Cancer Pain 1

Interventions

Radiosurgery 7lenvatinib 5Radiofrequency Ablation 5Electroporation 5Radiotherapy 3Patient Navigation 3Laparoscopy 3Hepatectomy 3Exercise 3sintilimab 2perflutren 2Surgical Procedures, Operative 2Standard of Care 2Proton Therapy 2Nutritional Status 2Magnetic Resonance Spectroscopy 2Liver Transplantation 2Injections 2Dextrins 2Cryosurgery 2Control Groups 2Bupivacaine 2Anesthesia, General 2toripalimab 1tislelizumab 1seocalcitol 1pembrolizumab 1motexafin gadolinium 1gadofosveset trisodium 1gadobutrol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Liver Neoplasms × Patient Education as Topic × Clear all
NCT02582918 2022-09-28

Texas Hepatocellular Carcinoma Consortium (THCCC) Project 5

University of Texas Southwestern Medical Center

Phase NA Completed
2,871 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡